SJ-BRV is novel therapeutic and prophylactic immunodrug for the treatment and prevention of obesity by controlling lipid metabolism in a stage of storage. The key to the SJ-BRV vaccine is to trick the immune system into making antibodies against self antigens. SJ-BRV works by eliciting antibodies that block the binding of lipids in receptors in the adipose tissue thus preventing lipid storage in the adipose tissue.
- Working on process development on candidate protein SJ-BRV
- Formulation Study in preparation
- Preparing non-clinical toxicity study design and clinical design